Founders Fund Leads $5M Anvil Token Purchase 
Evan Gershkovich Says FSB Set Trap for 2023 Russia Arrest 
Dollar Retreats From 18-Month High as Euro Rebounds 
Robinhood Buys $25 Million in Bitcoin for Corporate Treasury 
FDA Approves Mirum’s Atebrioz for Rare Bone Disorder FOP 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
LVMH-Hermès Dispute Deepens Over Secret 2002 Share Deal 
Indian Stocks Fall as RBI Hikes Rates to 5.50% 
Zcash Privacy Demand Rises as AI Exposes Bitcoin Transactions 
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 
Circle Stock Falls 4% as Crypto Selloff Overshadows SAP Pay Expansion 
European Stocks Diverge as French Fiscal Crisis Hits CAC 40 
Oil Prices Fall as Middle East Exports Recover, G7 Eases Supply Fears 
Trump Asks Supreme Court to Restore Third-Country Deportations 
CNN, MS NOW and Politico Sue Trump Over White House Media Ban 
Add as a preferred source on Google
The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.
